PUNE, India, April 4, 2016 /PRNewswire/ --
According to a new market research report "Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020", published by MarketsandMarkets, report provides a detailed overview of the major drivers, restraints, opportunities, and trends impacting the global virus filtration market along with the estimates and forecasts of the revenue and market share analysis.
Browse 74 market data Tables and 104 Figures spread through 185 Pages and in-depth TOC on "Virus Filtration Market"
Early buyers will receive 10% customization on this report.
The global virus filtration market is projected to reach USD 3.25 Billion by 2020 from USD 1.82 Billion in 2015, at a CAGR of 12.3% between 2015 and 2020. The rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. On the other hand stringent government regulations for validation of filtration products and highly consolidated market are the major factors restraining the growth of this market. Asian region and increasing pharmaceutical outsourcing presents high-growth opportunities in this market. Growing adoption of single-use technologies is an upcoming trend in the virus filtration market.
This report segments the global virus filtration market by product, application, end user, and geography. The products segments included in the market are kits and reagents, filtration systems, other products and services. Of these, the kits and reagents product segment accounted for the largest share of the global virus filtration market in 2015.
The application segments included in this report is biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products. The biologicals forms the largest and fastest-growing application segment in the global virus filtration market by 2020 and vaccines and therapeutics accounted for the major share of global biologicals segment in 2015.
On the basis of end user segments this report is classified into, pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. Of these, the pharmaceutical & biotechnology companies were the largest and CRO's are the fastest-growing end user segment in 2015.
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). The North America region includes U.S. and Canada. Asian regional segment includes China, Japan, India and RoA. Geographic analysis reveals that North America accounted for the largest share of the global virus filtration market in 2015. Growth in this market can be attributed to the growth of biopharmaceutical industry.
Speak to our Expert: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=157281944
The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).
Browse Related Reports:
Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 2019
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets